An in-depth look to Dogwood Therapeutics, Inc. operating, investing, and financing activities

DWTX free cash flow for Q2 24 is -811.75 k USD. For 2023, DWTX free cash flow was -4.87 M USD and operating cash flow was -4.87 M USD.